Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Indications and practice of artificial hydration for terminally ill cancer patients.

Nakajima N, Satake N, Nakaho T.

Curr Opin Support Palliat Care. 2014 Dec;8(4):358-63. doi: 10.1097/SPC.0000000000000089. Review.

PMID:
25211496
2.

[Treatment of gastrointestinal illness in palliative care].

Habek JC.

Acta Med Croatica. 2013 Jun;67(3):241-9. Review. Croatian.

PMID:
25007434
3.

Clinical impact of palliative treatment using octreotide for inoperable malignant bowel obstruction caused by advanced urological cancer.

Kubota H, Taguchi K, Kobayashi D, Naruyama H, Hirose M, Fukuta K, Kubota Y, Yasui T, Yamada Y, Kohri K.

Asian Pac J Cancer Prev. 2013;14(12):7107-10.

4.

[Palliative sedation for psycho-existential suffering].

Weichselbaumer E, Weixler D.

Wien Med Wochenschr. 2014 May;164(9-10):172-8. doi: 10.1007/s10354-013-0246-9. Epub 2013 Oct 25. German.

PMID:
24158418
5.

Quality of life and symptoms control in brain metastasis after palliative whole brain radiotherapy using two different protocols.

Akhtar MS, Kousar F, Fatmi S, Jabeen K, Akhtar K.

J Coll Physicians Surg Pak. 2012 May;22(5):311-6. doi: 05.2012/JCPSP.311316. Review.

PMID:
22538037
6.

Analgesia for terminally ill adult patients. Preserve quality of life.

[No authors listed]

Prescrire Int. 2011 Nov;20(121):268-73. Review.

PMID:
22066317
7.

Assessment and management of gastrointestinal symptoms in advanced illness.

McHugh ME, Miller-Saultz D.

Prim Care. 2011 Jun;38(2):225-46, viii. doi: 10.1016/j.pop.2011.03.005. Review.

PMID:
21628036
8.

[Clinical efficacy of octreotide acetate in cancer patients with malignant bowel symptoms depend on terminal stage].

Uchino R, Kusano S, Hanada N, Ohara C, Okino T, Yamaguchi K.

Gan To Kagaku Ryoho. 2011 Feb;38(2):255-7. Japanese.

PMID:
21368489
9.

A case of cancer pain management by long-term intrathecal PCA.

Sato C, Okabe T, Nakanishi K, Sakamoto A.

J Nippon Med Sch. 2010 Dec;77(6):333-7.

10.

Catumaxomab: malignant ascites: unjustified marketing authorisation.

[No authors listed]

Prescrire Int. 2010 Oct;19(109):207-9.

PMID:
21180374
11.

[Essential psychological care in palliative medicine].

Akechi T.

Seishin Shinkeigaku Zasshi. 2010;112(10):1029-36. Review. Japanese.

PMID:
21179667
12.

Non-cancer patients in specialized palliative care in Germany: what are the problems?

Ostgathe C, Alt-Epping B, Golla H, Gaertner J, Lindena G, Radbruch L, Voltz R; Hospice and Palliative Care Evaluation (HOPE) Working Group.

Palliat Med. 2011 Mar;25(2):148-52. doi: 10.1177/0269216310385370. Epub 2010 Oct 11.

PMID:
20937612
13.

Usefulness of droperidol as an anti-emetic in terminally ill cancer patients.

Thangathurai D, Roffey P.

J Palliat Med. 2010 Aug;13(8):939. doi: 10.1089/jpm.2010.0005. No abstract available.

PMID:
20712462
14.

Fatigue in children with cancer at the end of life.

Ullrich CK, Dussel V, Hilden JM, Sheaffer JW, Moore CL, Berde CB, Wolfe J.

J Pain Symptom Manage. 2010 Oct;40(4):483-94. doi: 10.1016/j.jpainsymman.2010.02.020. Epub 2010 Aug 1.

PMID:
20678889
15.

Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.

Hisanaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M, Kizawa Y, Maeno T, Shima Y, Hyodo I.

Jpn J Clin Oncol. 2010 Aug;40(8):739-45. doi: 10.1093/jjco/hyq048. Epub 2010 Apr 21.

16.

Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.

Konda A, Savin MA, Cappell MS, Duffy MC.

Gastrointest Endosc. 2009 Sep;70(3):561-7. doi: 10.1016/j.gie.2009.03.015. Epub 2009 Jul 4.

PMID:
19577743
17.

Presentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumors.

Gencer D, Kästle-Larralde N, Pilz LR, Weiss A, Buchheidt D, Hochhaus A, Hofheinz RD.

Onkologie. 2009 Jul;32(7):380-6. doi: 10.1159/000218355. Epub 2009 Jun 12.

PMID:
19556814
18.

Treatment of nausea and vomiting in terminally ill cancer patients.

Glare PA, Dunwoodie D, Clark K, Ward A, Yates P, Ryan S, Hardy JR.

Drugs. 2008;68(18):2575-90. doi: 10.2165/0003495-200868180-00004. Review.

PMID:
19093700
19.

Percutaneous transesophageal gastrostomy (PTEG): a safe and effective technique for gastrointestinal decompression in malignant obstruction and massive ascites.

Udomsawaengsup S, Brethauer S, Kroh M, Chand B.

Surg Endosc. 2008 Oct;22(10):2314-8. doi: 10.1007/s00464-008-9984-y. Epub 2008 Jul 12.

PMID:
18622539
20.

Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.

Shima Y, Ohtsu A, Shirao K, Sasaki Y.

Jpn J Clin Oncol. 2008 May;38(5):354-9. doi: 10.1093/jjco/hyn035.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk